Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan-Dec:25:2515690X20932523.
doi: 10.1177/2515690X20932523.

Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19

Hanan Polansky  1 , Gillad Lori  1
Affiliations
Review

Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19

Hanan Polansky et al. J Evid Based Integr Med. 2020 Jan-Dec.

Abstract

The coronavirus (SARS-CoV-2), which causes COVID-19, is a betacoronavirus closely related to the human severe acute respiratory syndrome (SARS)-coronavirus (SARS-CoV). The recent COVID-19 outbreak created an urgent need for treatment. To expedite the development of such treatment, pharmaceutical companies and government agencies are currently testing several existing drugs for their effect on the virus. Gene-Eden-VIR and Novirin are natural, broad-spectrum, antiviral treatments proven to be safe and effective in several clinical studies. In this article, we present evidence indicating that the 5 Gene-Eden-VIR/Novirin ingredients have anti-betacoronavirus, and specifically, anti-SARS-CoV effects. We consider this evidence as a first indication of the anti-coronavirus effects of Gene-Eden-VIR/Novirin. Next, we are planning to conduct a clinical study with users of the treatments to test the effects of Gene-Eden-VIR/Novirin on individuals at risk and those infected with the virus.

Keywords: COVID-19; SARS-CoV-2; coronavirus.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Hanan Polansky is the inventor of the Gene-Eden-VIR/Novirin formula. Gillad Lori has no conflict of interest to disclose.

References

    1. Zhao S, Lin Q, Ran J, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020;92:214–217. - PMC - PubMed
    1. Cao Z, Zhang Q, Lu X, et al. Estimating the effective reproduction number of the 2019-nCoV in China [published online January 29, 2020]. MedRxiv. doi:10.1101/2020.01.27.20018952
    1. World Health Organization (WHO). WHO Director-General's opening remarks at the media briefing on COVID-19 - 3 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re...
    1. Zhou P, Yang CL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273. doi:10.1038/s41586-020-2012-7 - PMC - PubMed
    1. Ceraolo C, Giorgi FM. Genomic variance of the 2019—nCoV coronavirus. J Med Virol. 2020;92:522–528. doi:10.1002/jmv.25700 - PMC - PubMed

LinkOut - more resources